NEW YORK (TheStreet) -- CHANGE IN RATINGS
was initiated with a Buy rating at UBS. $18 price target. Company could receive two product approvals before the end of the year, UBS said.
was started with an Equal-weight rating at Morgan Stanley. $100 price target. Company has emerging-markets exposure, but its North American business should grow even faster.
was initiated with a Market Perform rating at Leerink Swann. Company is performing well within a slow period of growth for the industry.
was downgraded to Hold at Deutsche Bank. Valuation call, based on a $25 price target.
was initiated with an Overweight rating at Morgan Stanley. $55 price target. Truck sales should grow over the coming years, even without an economic recovery.
was downgraded to Hold at Deutsche Bank. $65 price target. Stock is already pricing in better domestic tobacco fundamentals.
was initiated with a Neutral rating at UBS. $45 price target. Visibility remains low for the ability of a Xifaxan sales ramp.
was downgraded from Buy to Hold at Soleil Securities. Valuation call, based on a $23 price target.
was downgraded at Citigroup from Buy to Hold. $30 price target. Estimates also cut, as promotional activity is likely to increase in the industry.
( TLAB) was downgraded at Morgan Keegan from Outperform to Market Perform, Morgan Keegan said. Company is facing flat sales for 2011.
STOCK COMMENTS / EPS CHANGES
shares now seen reaching $360, according to Stifel Nicolaus. Estimates also increased, given continued iPad growth.
estimates were boosted through 2012, Citigroup said. Industrial organic revenue growth should continue to be impressive. Hold rating and new $25 price target.
( CEG) estimates boosted at Morgan Stanley through 2012. Company should realize higher margins, given its NewEnergy guidance. Equal-weight rating and $31 price target.
estimates were reduced through 2012 at Goldman Sachs. Company is likely to cut into earnings, by increasing marketing spending. Neutral rating and new $81 price target.
now seen reaching $15.50, according to Jefferies. New Texas rate decision could boost earnings. Hold rating.
shares now seen reaching $46, according to Goldman Sachs. Estimates also increased, given the company's accelerated store growth and buyback progra. Neutral rating.
shares now seen reaching $160, according to Jefferies. Estimates also increased, given higher expected solar pricing. Hold rating.
was added to the Top Picks List at FBR Capital Markets. Stock should benefit from the company's higher order and backlog growth.
estimates were raised through 2012 at Morgan Stanley. Company is cutting costs and should benefit from improving credit. Overweight rating and $78 price target.
United Natural Foods
estimates were lowered through 2012, Citigroup said. Secondary offering will dilute earnings, though core trends are likely to remain strong. Buy rating and $42 price target.
shares now seen reaching $108, according to Sterne Agee. Estimates also reduced, given apparent market share losses in Macau. Buy rating.
This article was written by a staff member of TheStreet.